FDA Inspection
Hill Dermaceuticals, Inc.Hill Dermaceuticals, Inc. – FDA Inspection, Aug 11, 2021
Record Details
This FDA Inspection record concerns Hill Dermaceuticals, Inc., with an inspection on August 11, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Hill Dermaceuticals, Inc.
- Inspection Date
- August 11, 2021
- Product Type
- Drugs
View Company Profile
ID · e504194c-48f3-4faa-9d20-bba5213c3ffc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1149082
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.84(d)(6)Microbiological Contamination Exam
- 21 CFR 211.52Washing and toilet facilities are deficient
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hill Dermaceuticals, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 14, 2025 | VAI | Florida District Office | Drug Quality Assurance |
| May 18, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 6, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hill Dermaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.